A next-generation treatment from Novo Nordisk helped patients with diabetes lower their blood sugar and lose weight in a ...

Like an estimated 20 million Americans, I have an incurable post-acute infection syndrome that goes by the name of long Covid ...

The lung cancer screening system “is not a risk assessment. It is a judgment system designed as one,” writes the director of ...

A federal commission is calling for significant changes to the way the U.S. government funds and assesses scientific research ...

Medicare officials have backed off a plan that would have clawed back $7.8 billion from hospitals a decade sooner than ...

Friends…hello. I’m BACK. My wife and I welcomed a new baby a few months ago. We now have two kids (still weird to say kids, ...

With backlash growing to surging health insurance costs, Trump is floating a temporary extension of extra ACA subsidies.

Novo Nordisk's blockbuster weight loss drug semaglutide failed to slow Alzheimer's progression in trials. The studies had ...

A promising Alzheimer’s treatment failed to slow the progress of the disease, news that could dampen enthusiasm for a new class of potential medicines.

Novo Nordisk’s weight loss drug semaglutide failed to slow the progression of Alzheimer’s disease in two large trials ...

Novo Nordisk said this morning that a pair of large, placebo-controlled clinical trials testing an oral version of its GLP-1 ...

The underlying premise of neurodiversity is that there are people who are different from the norm; these people are not ...